Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02311998
Title Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center

B-cell acute lymphoblastic leukemia

chronic myeloid leukemia


Bosutinib + Inotuzumab ozogamicin

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST